Loading...

Abbott introduces new DRG Invisible Trial System for chronic pain management

Abbott has announced the launch of the new DRG Invisible Trial System, approved by the US Food and Drug Administration (FDA) and received CE Mark in Europe.

People suffering from complex chronic pain conditions can now use the DRG Invisible Trial System to try Abbott’s dorsal root ganglion (DRG) stimulation—it’s clinically proven, non-opioid treatment option for targeted chronic pain management.

Patients who are relieved with DRG therapy can then have Abbott’s Proclaim DRG system implanted, it empowers them to manage their pain with familiar Apple consumer technology.

Know More

👇🏻 Please Share

Leave a Reply

Your email address will not be published. Required fields are marked *

Your Health in Your Hand

Don’t let your health go up in smoke

Environmental medicine is the study of how toxins affect the health of a person, and in this field of medicine,...

India set to generate global fund for AIDS, TB & Malaria program

India is ready to set funds for AIDS, TB and malaria program and sustain health systems across the world. With...

Inaccurate diagnosis results in medical blunders. Comment!

According to WHO (World health organization), out of every 10 patients in the world, 1 patient is killed due to...

Using of Digital Health Records has Less Environment Strain

Automation and digitization of health records is definitely an important step in healthcare technology. With the greater use of electronic...

Leveraging the power of technology in managing your personal health

There has been a tremendous growth in terms of technology in the healthcare sector. Patients are forced to play new...